Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 of  108,472 نتائج ل ""CYSTIC fibrosis""

فلترة النتائج

فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Cystic fibrosis.
Research Starter

Cystic fibrosis.

  • Genetic diseases are inherited rather than caused by any specific injury or infectious agent. Thus, unlike many other types of ... More
  • Magill’s Medical Guide (Online Edition), 2023. 3p.
Academic Journal

Functional Consequences of CFTR Interactions in Cystic Fibrosis.

  • Authors : Ramananda Y; Department of Pediatrics, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/metabolism; Humans ; Cystic Fibrosis Transmembrane Conductance Regulator/Cystic Fibrosis Transmembrane Conductance Regulator/Cystic Fibrosis Transmembrane Conductance Regulator/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 16; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion.

  • Authors : Lefferts JW; Department of Pediatric Respiratory Medicine, Wilhelmina Children's Hospital, University Medical Center, Utrecht University, 3584 EA, Utrecht, The Netherlands.; Regenerative Medicine Utrecht, University Medical Center, Utrecht University, 3584 CT, Utrecht, The Netherlands.

Subjects: Deep Learning* ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/genetics; Humans

  • Source: Communications biology [Commun Biol] 2024 Mar 13; Vol. 7 (1), pp. 319. Date of Electronic Publication: 2024 Mar 13.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Evaluation of the efficiency of nanomicellar formulation of fat-soluble vitamins in patients with cystic fibrosis: the study protocol for a randomized controlled trial.

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/diagnosis ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy; Child

  • Source: Trials [Trials] 2024 Jan 16; Vol. 25 (1), pp. 60. Date of Electronic Publication: 2024 Jan 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Exploring the Mechanism of Activation of CFTR by Curcuminoids: An Ensemble Docking Study.

  • Authors : Bellacchio E; Genetica Molecolare e Genomica Funzionale, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Subjects: Curcumin*/Curcumin*/Curcumin*/pharmacology ; Cystic Fibrosis*; Humans

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 31; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor-Tezacaftor-Ivacaftor therapy.

  • Authors : Martin C; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.; Guzior DV

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/diagnosis ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/genetics

  • Source: Respiratory research [Respir Res] 2023 Dec 16; Vol. 24 (1), pp. 317. Date of Electronic Publication: 2023 Dec 16.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cystic Fibrosis Mice Are Highly Susceptible to Repeated Acute Pseudomonas aeruginosa Pneumonia after Intranasal Inoculation.

  • Authors : Manzor M; Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, Boston, USA.; Koutsogiannaki S

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/genetics ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/microbiology ; Pneumonia*/Pneumonia*/Pneumonia*/complications

  • Source: BioMed research international [Biomed Res Int] 2024 Feb 05; Vol. 2024, pp. 4769779. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Inhibition of mucus secretion by niclosamide and benzbromarone in airways and intestine.

  • Authors : Ousingsawat J; Physiological Institute, University of Regensburg, University Street 31, 93053, Regensburg, Germany.; Centeio R

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy ; Asthma*; Humans

  • Source: Scientific reports [Sci Rep] 2024 Jan 17; Vol. 14 (1), pp. 1464. Date of Electronic Publication: 2024 Jan 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Compound heterozygous mutations in CFTR causing congenital bilateral absence of the vas deferens in a Chinese pedigree.

  • Authors : Li L; Department of Reproductive Medicine Center, People's Hospital of Henan University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.; Qu X

Subjects: Infertility, Male*/Infertility, Male*/Infertility, Male*/genetics ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/genetics ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/pathology Congenital bilateral aplasia of vas deferens

  • Source: Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2024 Jan; Vol. 12 (1), pp. e2364.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101603758 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.

  • Authors : McDonald EF; Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States of America.; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/genetics; Humans ; Cystic Fibrosis Transmembrane Conductance Regulator/Cystic Fibrosis Transmembrane Conductance Regulator/Cystic Fibrosis Transmembrane Conductance Regulator/metabolism

  • Source: PloS one [PLoS One] 2024 Jan 25; Vol. 19 (1), pp. e0297560. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study.

  • Authors : Cellini B; Department of Medicine and Surgery, University of Perugia, P.le Lucio Severi 1, 06132, Perugia, Italy. .; Pampalone G

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy; Humans ; Animals

  • Source: Scientific reports [Sci Rep] 2023 Dec 20; Vol. 13 (1), pp. 22692. Date of Electronic Publication: 2023 Dec 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 of  108,472 نتائج ل ""CYSTIC fibrosis""